| Revenue growth | FY26 Net Sales grew 11.23% YoY to ₹502.55 Cr. |
|---|---|
| Margins | Higher raw material prices in Beverages; lower prices in OTC. |
| Demand visibility | Positive outlook with relaunch of Relief brand and new capacity. |
| Management confidence | Confident in demand environment and unique value propositions. |
Growth
FY26 Net Sales grew 11.23% to ₹502.55 Cr. FY26 PAT rose 13.95% to ₹57.92 Cr.
Outlook
New sanitary pad plant starting May 2026; target 100k chemists by Sept FY27; relaunching Relief brand.
Risks
COGS inflation due to Middle East wars affecting crude prices and supply chains; legal lease rent charge.
Earnings Call filed with BSE, NSE: AMRUTANJAN. Summary written with AI assistance from the document.
Amrutanjan Health Care Ltd: key numbers
- Share price
- ₹521.55
- Market cap
- ₹1,508 Cr
- Revenue (annual)
- ₹502.6 Cr
- Net profit (annual)
- ₹57.92 Cr
- P/E (TTM)
- 27.9×Sector 47.3×
- Promoter holding
- 46.52%+0.00% QoQ
- FII holding
- 2.44%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amrutanjan Health Care Ltd
All →Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited held its 89th AGM on September 23, 2026. The meeting transacted business including the adoption of accounts, dividend declaration, and director re-appointment.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend of Rs. 2.90 per share.
Amrutanjan Health Care Annual General Meeting
Amrutanjan Health Care Limited has issued a notice for its 89th Annual General Meeting on September 23, 2026. Key agenda items include adopting financial statements and declaring a final dividend.
- Value
- ₹0.06 Cr
Amrutanjan Health Care Business Update
Amrutanjan Health Care Limited submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26. This disclosure forms part of the company's Annual Report requirements.
Amrutanjan Health Care Annual Report
Amrutanjan Health Care Limited submitted its 89th Annual Report for the financial year 2025-26. The company scheduled its Annual General Meeting for September 23, 2026.
Amrutanjan Health Care Investor Presentation: Key Takeaways
Amrutanjan reported 9.48% revenue growth in Q1 FY27, driven by Women's Hygiene (21%) and Beverages (11.34%). Profitability was hit by a one-time INR 2.02 Cr lease rent provision.
- Call
- Guides 10% growth